Cargando…
Elevated pre-surgical CA15-3: does it predict the short-term disease-free survival of breast cancer patients without distant metastasis?
BACKGROUND: CA15-3 is the most commonly used tumor marker in breast cancer. Its prognostic role has been described in the metastatic setting, but the role of pre-surgical CA15-3 in the assessment of patients with breast cancer without metastasis has not been substantiated yet. METHODOLOGY: From Febr...
Autores principales: | Mudduwa, Lakmini KB, Wijayaratne, Gaya B, Peiris, Harshini H, Gunasekera, Shania N, Abeysiriwardhana, Deepthika, Liyanage, Nimsha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027693/ https://www.ncbi.nlm.nih.gov/pubmed/29983596 http://dx.doi.org/10.2147/IJWH.S162867 |
Ejemplares similares
-
KIBRA; a novel biomarker predicting recurrence free survival of breast cancer patients receiving adjuvant therapy
por: Mudduwa, Lakmini, et al.
Publicado: (2018) -
Prognostic Significance of Low Claudin3 Expression in Luminal Breast Cancers
por: Mudduwa, Lakmini, et al.
Publicado: (2017) -
Validity of St Gallen risk categories in prognostication of breast cancer patients in Southern Sri Lanka
por: Peiris, Harshini, et al.
Publicado: (2018) -
Barleria prionitis L. extracts ameliorate doxorubicin-induced acute kidney injury via modulation of oxidative stress, inflammation, and apoptosis
por: Amarasiri, Sachinthi S., et al.
Publicado: (2023) -
Distant metastasis in patients with myxofibrosarcoma
por: Tsuchie, Hiroyuki, et al.
Publicado: (2017)